Targeting Strategies for Osteoarthritis: Biomaterials, Joint‐Specific Drug Delivery, and Translational Progress
Advanced Healthcare Materials · 2026-05 · 15 (18)
DOI: 10.1002/adhm.202504577 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Healthcare Materials, online erschienen am 04.03.2026. Verfasst von Haozhe Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oral Diseases & National Center For Stomatology & National Clinical Research Center for Oral Diseases, West China Hospital of…. Hauptthemen laut MEDLINE: Osteoarthritis, Biocompatible Materials, Drug Delivery Systems, Translational Research, Biomedical. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 282 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Sichuan Science and Technology Program.
Abstract (Originalsprache)
Osteoarthritis (OA) is a chronic degenerative joint disease characterized by progressive destruction of joint structures and loss of mobility. The efficacy of current therapies is limited by the dense extracellular matrix of cartilage, rapid drug clearance by synovial fluid, and the complex anatomical and biomechanical features of specialized fibrocartilaginous and cartilaginous tissues such as the intervertebral disc, meniscus, and temporomandibular joint (TMJ) disc. Recent advances highlight the potential of exploiting OA‐specific microenvironmental cues—most notably acidic pH and elevated reactive oxygen species (ROS)—to achieve targeted and responsive treatment. This review first introduces bioreactor technologies that simulate physiological and pathological joint environments, providing powerful platforms for studying OA pathogenesis and screening therapies. We then examine microscopic changes in joint structure, composition, and mechanical properties that represent both barriers and therapeutic opportunities. Particular emphasis is placed on smart biomaterials that respond to pH or ROS for site‐specific drug delivery and controlled release. In addition, we summarize tissue‐specific targeting strategies for superficial and deep cartilage layers and discuss delivery systems tailored to complex joint structures. Finally, we outline translational progress, including disease‐modifying osteoarthritis drug candidates and clinically tested delivery systems, and highlight emerging approaches that may bridge laboratory research and clinical application.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Oral Diseases & National Center For Stomatology & National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan, China.
- AO Research Institute Davos, Davos, Switzerland.
ORCID-Profile: Nan Jiang
Förderung
- National Natural Science Foundation of China
- Sichuan Science and Technology Program
Zitieren
APA
Chen, H., Sun, J., Liao, Y., Cao, P., Su, Z., Ren, R., Mao, Y., Li, Z., Zhu, S., & Jiang, N. (2026). Targeting Strategies for Osteoarthritis: Biomaterials, Joint‐Specific Drug Delivery, and Translational Progress. Advanced Healthcare Materials, 15(18). https://doi.org/10.1002/adhm.202504577
Vancouver
Chen H, Sun J, Liao Y, Cao P, Su Z, Ren R, et al. Targeting Strategies for Osteoarthritis: Biomaterials, Joint‐Specific Drug Delivery, and Translational Progress. Advanced Healthcare Materials. 2026;15(18). doi:10.1002/adhm.202504577
BibTeX
@article{Chen2026,
author = {Chen, Haozhe and Sun, Jialin and Liao, Yue and Cao, Pinyin and Su, Zhan and Ren, Rong and Mao, Yi and Li, Zhen and Zhu, Songsong and Jiang, Nan},
title = {Targeting Strategies for Osteoarthritis: Biomaterials, Joint‐Specific Drug Delivery, and Translational Progress},
journal = {Advanced Healthcare Materials},
year = {2026},
volume = {15},
number = {18},
doi = {10.1002/adhm.202504577}
}
EUVIMED